Clinical Trial Update: Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials [Phase 3]

View source ↗

Summary

Open-label extension study of Etanercept (TNFR:Fc) in rheumatoid arthritis completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (Enbrel) (Etanercept)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2010-12-06